Similar articles for PMID: 18489402

Year	Number of Results
1994	1
1995	1
1997	1
1998	2
2000	3
2001	4
2002	4
2003	9
2004	8
2005	9
2006	9
2007	15
2008	11
2009	9
2010	9
2011	11
2012	7
2013	4
2014	8
2015	7
2016	4
2019	1
2020	1
2021	1
2024	0

1

Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection.

Reiberger T, Rasoul-Rockenschaub S, Rieger A, Ferenci P, Gangl A, Peck-Radosavljevic M. Reiberger T, et al. Eur J Clin Invest. 2008 Jun;38(6):421-9. doi: 10.1111/j.1365-2362.2008.01958.x. Eur J Clin Invest. 2008. PMID: 18489402

2

Hepatitis C virus viral kinetics during α-2a or α-2b pegylated interferon plus ribavirin therapy in liver transplant recipients with different immunosuppression regimes.

Berenguer M, Ortíz-Cantó C, Abellán JJ, Aguilera V, Rubín A, Prieto M, López-Labrador FX. Berenguer M, et al. J Clin Virol. 2012 Mar;53(3):231-8. doi: 10.1016/j.jcv.2011.12.005. Epub 2012 Jan 4. J Clin Virol. 2012. PMID: 22222052 Clinical Trial.

3

Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppression.

Mira JA, Gutiérrez-Valencia A, Gil Ide L, Merino D, Rivero A, Ríos-Villegas MJ, Delgado M, González-Serrano M, Collado A, Torres-Tortosa M, Omar M, López-Ruz MA, Macías J, Arponen S, Pineda JA. Mira JA, et al. Clin Infect Dis. 2009 Oct 15;49(8):e84-91. doi: 10.1086/605677. Clin Infect Dis. 2009. PMID: 19772388

4

Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.

Antonini TM, Furlan V, Teicher E, Haim-Boukobza S, Sebagh M, Coilly A, Bonhomme-Faivre L, Roque-Afonso AM, Vittecoq D, Samuel D, Taburet AM, Duclos-Vallée JC. Antonini TM, et al. AIDS. 2015 Jan 2;29(1):53-8. doi: 10.1097/QAD.0000000000000516. AIDS. 2015. PMID: 25387314

5

Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study.

Tural C, Solà R, Rubio R, Santín M, Planas R, Quereda C, Berenguer J, Montes-Ramírez M, Clotet B; CORAL-1 study group. Tural C, et al. J Viral Hepat. 2007 Oct;14(10):704-13. doi: 10.1111/j.1365-2893.2007.00860.x. J Viral Hepat. 2007. PMID: 17875005 Clinical Trial.

6

Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infection.

Duvoux C, Villamil F, Renner EL, Grazi GL, Firpi RJ, Pageaux G, Mulhaupt B, Schirm F, Rauer B, Bernhardt P, Levy G. Duvoux C, et al. Ann Transplant. 2015 Jan 15;20:25-35. doi: 10.12659/AOT.892032. Ann Transplant. 2015. PMID: 25588713 Free article. Clinical Trial.

7

Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.

Cimsit B, Assis D, Caldwell C, Arvelakis A, Taddei T, Kulkarni S, Schilsky M, Emre S. Cimsit B, et al. Transplant Proc. 2011 Apr;43(3):905-8. doi: 10.1016/j.transproceed.2011.02.034. Transplant Proc. 2011. PMID: 21486625

8

Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy.

Rodríguez-Torres M, Rodríguez-Orengo JF, Ríos-Bedoya CF, Fernández-Carbia A, González-Lassalle E, Salgado-Mercado R, Marxuach-Cuétara AM. Rodríguez-Torres M, et al. J Clin Virol. 2007 Jan;38(1):32-8. doi: 10.1016/j.jcv.2006.09.009. Epub 2006 Oct 24. J Clin Virol. 2007. PMID: 17064957 Clinical Trial.

9

Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load.

Tsubota A, Arase Y, Someya T, Suzuki Y, Suzuki F, Saitoh S, Ikeda K, Akuta N, Hosaka T, Kobayashi M, Kumada H. Tsubota A, et al. J Med Virol. 2005 Jan;75(1):27-34. doi: 10.1002/jmv.20232. J Med Virol. 2005. PMID: 15543591 Clinical Trial.

10

Open, randomized, multicentre italian trial on PEG-IFN plus ribavirin versus PEG-IFN monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART.

Cargnel A, Angeli E, Mainini A, Gubertini G, Giorgi R, Schiavini M, Duca P; Italian Co-infection Study (ICOS) Group. Cargnel A, et al. Antivir Ther. 2005;10(2):309-17. Antivir Ther. 2005. PMID: 15865225 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

128 results

Results by year